January 2, 2019


From Merck Fast Track to Computer Chem Frontier: Karen Akinsanya on The Long Run

Today’s guest on The Long Run is Karen Akinsanya. Karen is the chief biomedical scientist at Schrodinger. The New York-based company is a leader in computational chemistry for drug discovery. The company is privately held, and not a household name. But some wealthy and powerful people know it well. Schrodinger counts Bill Gates and David E. Shaw, the hedge fund...
Read More